Imatinib mesylate (IM), a widely prescribed powerful tyrosine kinase inhibitor, has been associated with increased risk of heart failure and is known to induce cell apoptosis and death in isolated cardiomyocytes. In addition to acquired long QT syndrome, pharmacological inhibition of human ether-à-go-go-related gene (HERG) channel has been reported to involve in apoptosis. The present study was undertaken to characterize the biophysical properties of IM on HERG and the molecular determinants of HERG blockade using mutant channels ( 
Repolarization of cardiac action potentials (APs) is controlled by a number of potassium channels. Among the cardiac potassium currents, the rapid delayed rectifier potassium current (I Kr ), is the most critical for terminating the AP, and it determines the shape of the APs. The human ether-à-go-go-related gene (HERG) encodes the pore-forming α-subunit of I Kr . It has been established that suppression of the HERG function, either by genetic defects or drug side effects, can induce long-QT syndrome characterized by a prolonged QT interval on an electrocardiogram and fatal arrhythmias such as torsade de pointes (TdP). 1, 2) Additional to cardiac tissue, the HERG channel is highly expressed in tumor cells and is involved in the regulation of cell proliferation and apoptosis, 3, 4) which may be a potential target for cancer therapy. However, HERG-related apoptosis has also been identified in cardiomyocytes and may contribute to heart failure in patients treated with certain HERG inhibitors such as doxazosin and amoxapine. 5) HERG-linked effects represent a significant cardiovascular liability of clinical and developmental drugs. Tyrosine kinase inhibitors are particularly toxic as they are associated with acquired QT prolongation, Tdp and heart failure. 6, 7) Imatinib mesylate (IM) is a powerful tyrosine kinase inhibitor, which has revolutionized the treatment of chronic myeloid leukemia (CML), as well as the management of advanced gastrointestinal stromal tumor (GIST). 8, 9) Although IM induced less QTprolonging effects compared to other tyrosine kinase inhibitors, concerns have been reported on disturbances in conduction and rhythm, depression of myocardial function and heart failure. 10, 11) In vitro, IM induced significant cell apoptosis and death in isolated cardiomyocytes. 12, 13) Additionally, IM targets cellular mechanisms other than tyrosine kinase, including voltage-gated potassium and calcium channels. [14] [15] [16] [17] Furthermore, we have recently shown that IM significantly reduces HERG currents as well as its expression in CML. 18) However, to date, there have not been any published reports relating to the electrophysiological characteristics of IM interacting with the HERG channel. Therefore, the present study was aimed to investigate the effects of IM on HERG channel expressed in HEK-293 cells and Xenopus oocytes and to characterize its inhibitory effect on the HERG channel and to identify the key molecular determinants of HERG blockade using mutant channels (Y652A and F656A).
MATERIALS AND METHoDS

HEK-293
Cell Culture and Transfection HEK-293 cells were purchased from the ATCC. The wild-type HERGpEGFP-N2 vector was obtained from Dr. Zhengfeng Zhou, oregon Health and Science University, U.S.A. Cells were transiently transfected with this construct by Lipofectamine 2000 (Invitrogen) according to the manufacturer's procedures. The transfected cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 1 mmol/L sodium pyruvate, 0.1 mmol/L non-essential amino acid solution, 100 U/mL penicillin, and 100 µg/mL streptomycin sulfate. The cultures were passaged after 24 h transfection with a brief trypsin-ethylenediaminetetraacetic acid (EDTA) treatment followed by seeding onto 12 mm diameter glass coverslips in a Petri dish. The cell-attached coverslips were used for electrophysiological recordings.
Patch-Clamp Recording The whole-cell patch-clamp method was used for HERG currents (I HERG ) of HEK-293 cells transiently transfected with HERG. 18, 19) The bath solution contained (in mmol/L): 137 NaCl, 4 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 N-(2-hydroxyethyl) piperazine-N′-2-ethanesulfonic acid (HEPES) (pH 7.4 with NaoH). The pipette solution contained (in mmol/L): 130 KCl, 1 MgCl 2 , 5 ethylene glycol bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), 5 Mg-ATP, 10 HEPES (pH 7.2 with KoH). Electrodes were pulled from glass capillaries (VitalSense Scientific Instruments, Wuhan, China) using a Flaming/Brown P-97 pipette puller (Sutter Instrument, San Rafael, CA, U.S.A.). Electrodes typically had a resistance of 2-4 MΩ. Currents were amplified and filtered using an Axopatch 200B amplifier, and digitized with a Digidata 1322A (Molecular Devices, Union City, CA, U.S.A.) at 5 kHz after analog filtering with the amplifier's four-pole low-pass Bessel (2 kHz). All experiments were performed at room temperature.
Heterologous Expression of HERG in Xenopus Oocytes Isolation and maintenance of Xenopus oocytes and injection with cRNA were performed as described. 20, 21) Point mutations were introduced into the HERG channel (Y652A and F656A) and subcloned into the pSP64 plasmid expression vector, which were kindly given by Dr. Michael C. Sanguinetti from the University of Utah. Complementary RNA were prepared with SP6 mMESSAGE mMachine Kit (Ambion, Austin, TX, U.S.A.) following linearization with an excess of EcoRI. Estimates of cRNA quality and quantity were determined by UV spectroscopy and then stored at −80°C until required. Stage IV or V Xenopus laevis oocytes were carefully injected with 41 nL cRNA (0.5-1 µg/µL) and cultured in modified ND96 solution supplemented with 100 U/mL penicillin, 100 U/mL streptomycin and 2.5 mmol/L sodium pyruvate. The modified ND96 solution contained (in mmol/L): 94 NaCl, 4 KCl, 1.8 CaCl 2 , 2 MgCl 2 , 5 HEPES and was adjusted to pH 7.5 using NaoH.
Two-Electrode Voltage Clamp
The standard twomicroelectrode voltage-clamp technique (A TEV-200 amplifier, Dagan Corporation) was used to record currents from Xenopus oocytes at room temperature (20-24°C), 1-2 d after cRNA injection. Glass microelectrodes were filled with 3 mol/L KCl, and their tips were broken to obtain resistances of 0.5-2 MΩ. All signals were filtered at 5 kHz low pass before digitalization at 5-10 kHz.
Chemicals Imatinib mesylate was purchased from Biovision (San Francesco, CA, U.S.A.). The powder was dissolved in dimethylsulfoxide (DMSo) to a concentration of 100 mmol/L stock and stored at −20°C, and diluted directly with bath solution to the desired concentration each day. All other chemicals were purchased from Sigma.
Statistical Analyses Clampfit 9.2 software (Molecular Devices) was used for data collection and analysis. origin 8.5 software (Microcal Software, Northampton, MA, U.S.A.) was used to fit the data and calculate time constants. Percentage inhibition was defined as follows: inhibition %=(1−I drug /I con )·100%, where I con and I drug are the current amplitudes in the absence and the presence of IM, respectively. Dose-response curves were fitted using the Hill equation:
, where B max is the maximum block of currents; IC 50 is the concentration of IM for the half-maximum block; D is the concentration of IM, and h is the Hill coefficient. The activation curve was approximated by the normalized conductance-voltage relationship and fitted with a Boltzmann distribution:
where A is the amplitude term, V 1/2 is the midpoint of activation, V m is the test potential, and k represents the slope factor of the curve. Results are presented as mean± S.E.M. Paired or unpaired Student's t-tests or ANoVA were used for statistical comparisons as appropriate. A value of p<0.05 was considered to be statistically significant.
RESULTS
Concentration-Dependent Blocking of Wild Type (WT)
I HERG by IM in HEK-293 Cells WT I HERG was elicited by a 5 s step to 0 mV from a holding potential of −80 mV, followed by repolarization to −50 mV for 5 s to produce tail currents. The voltage protocol was repeated every 15 s before and after perfusion with IM. Figure 1A shows the original recordings from the WT HERG channel before and after the successive application of 3, 10, 30 and 100 µmol/L IM. The concentration-dependent inhibition of the peak tail current was analyzed quantitatively (Fig. 1B) . A nonlinear least-squares fit of concentration-response plotted using the Hill equation yielded an IC 50 and Hill coefficient of 19.51± 2.50 µmol/L and 0.90± 0.10 (n=6), respectively. Meanwhile, the blocking effect was partially reversible (Fig. 1C) . Control currents were elicited by the above-described pulse protocol and lasted about 5 min to assure a steady-state condition. IM was then applied at a concentration of 30 µmol/L to the bath solution and caused the steady-state inhibition in 4-5 min. The inhibitory effect of IM was 70% reversed after 10 min of washout.
Voltage-Dependent Blocking of WT HERG Current by IM in HEK-293 Cell Voltage-dependent effects of IM on WT I HERG were investigated by applying command from a holding potential of −80 mV to test potentials ranging from −60 to +60 mV at a 10 mV increment. Each test pulse was followed by a repolarization step to −50 mV for the analysis of tail currents. An example of WT I HERG recording before and after the addition of IM (30 µmol/L) on the same cell was shown in Fig. 2A . The average normalized I-V relationship Tail currents in the control and the IM sample were also used to ascertain parameters describing I HERG activation (Fig.  2E) . In the control, the values of V 1/2 and k were −15.48± 1.21 mV and 7.82± 0.41 mV, respectively. In the IM sample, the values of V 1/2 and k were −26.66± 2.98 mV and 7.15± 1.83 mV, respectively. Thus, IM produced a leftward shift in the I HERG activation (p<0.05, n=6).
Effect of IM on the Inactivation of WT HERG Channels in HEK-293 Cells The effect of IM on the inactivation of WT HERG channels was assessed using a 3-step protocol shown in the inset of Fig. 3A . After a 2 s pulse of +40 mV, the membrane potential was held at various test voltages ranging from −120 to +40 mV for 20 ms to allow inactivation to relax to a steady-state, followed by a return step to +40 mV. The peak current elicited by the second step to +40 mV provided a relative number of open conducting channels, while the reinactivation of HERG was rapid to a +40 mV pulse and partially obscured by the capacity transient (Fig. 3A) . Therefore, the peak outward current during the third pulse was estimated by fitting the current traces beginning 3 ms after depolarization with a mono-exponential equation and extrapolating to the beginning of the pulse. Peak current amplitudes were normalized to the control current at −120 mV and plotted as a function of the voltage of the 20 ms test pulse (steady-state inactivation curve) and fitted to a Boltzmann function (Fig.  3B) fitting a mono-exponential function to the decaying current traces. The onset of inactivation was accelerated at −80 and −60 mV, but significant differences between the control and drug application over a wide range of voltages were not observed (Fig. 3C) . IM at 30 µmol/L had little effect on the rates of inactivation. 
Effect of IM on Deactivation of WT HERG Channels in HEK-293 Cells
The effect of deactivation of I HERG was examined using the dual-pulse protocol (Fig. 4A) . The cells were depolarized to +60 mV for 1 s to inactivate the HERG channels and then repolarized to potentials between −120 mV and +20 mV. IM reduced the tail currents within the wide range of test potential (Fig. 4B) 05, n=6, Fig. 4C ).
Time-Dependent Blocking of WT I HERG by IM in Xenopus Oocytes The time course for the development of the WT I HERG block by IM was assessed using an envelope of tails protocol in Xenopus oocytes. The membrane potential was held at −80 mV and stepped up to +40 mV, increasing the durations between 30 and 410 ms, after which HERG tails were evoked on repolarization to −40 mV. original current traces before and after the addition of IM (100 µmol/L) were shown in Fig. 5A . The time dependence of evoked tail activation was fitted with a mono-exponential equation, yielding a τ of 76.66± 6.33 ms for control and 61.06± 3.17 ms for IM (n=6, p<0.05, Fig. 5B ). Data were also analyzed by plotting the percentage inhibition against each of the different duration test-pulses (Fig. 5C) . The plot shows that the WT I HERG blockade by IM with brief depolarization was lower compared to a longer duration pulse. These data indicate that the blockade was enhanced by the further activation of current, which is concordant with the drug being able to move the channel into the open-state.
Concentration-Dependent Blocking of WT, Y652A, F656A HERG Currents by IM in Xenopus Oocytes Previous studies have shown that two aromatic residues, Tyr-652 and Phe-656, located in the S6 domain and face the pore cavity of the channel, are critical binding sites for a number of compounds. 22, 23) To determine whether these two key residues are also important for the blocking of HERG by IM, the potency of the channel block by IM for WT and mutant channels (Y652A and F656A) were compared in Xenopus oocytes. The effects of IM on WT and mutant channels were quantified during a 2-s activating pulses to 0 mV from a holding potential of −80 mV, then the tail currents were evoked by repolarization to −50 mV. As shown in Fig. 6 , 100 µmol/L IM produced markedly less inhibition of the mutant channels (Y652A and F656A) compared with the WT HERG. WT HERG channels tail currents in oocytes were inhibited by IM in a concentration-dependent manner with IC 50 of 44.76± 1.54 µmol/L. The IC 50 for Y652A channel block was 266.28± 15.51 µmol/L, 5.9-fold less sensitive compared with the WT channel (Fig. 6D) . The IC 50 value for the F656A mutant channel was 197.89± 60.97 µmol/L, 4.4-fold less sensitive compared with the WT channel (Fig. 6D) . There was no significant difference between the inhibitory effects of Y652A and F656A (p>0.05,  n=6) . These results indicate that the Y652 and F656 mutant 
DISCUSSIoN
In this study we have examined the electrophysiological effects of IM on the cloned HERG channel. The findings add complementary data to the understanding of the cardiovascular risk profile of IM.
IM is currently used as a first-line treatment for CML and GIST, 8, 9) with a clinically relevant plasma dosing range between 4.4 and 7.5 µmol/L. 24, 25) Protein binding for IM is reported to be 89-96%. 24) Considering the IC 50 values (ca. 20 µmol/L) that blocked the HERG WT channel expressed in HEK-293 cells is close to the range of therapeutic plasma concentration, it is reasonable to assume that HERG inhibition by IM may be clinical relevance. Moreover, IM is often used for long-term anticancer therapy, allowing for accumulation of the compound in cardiac tissue. Drug-induced QT prolongation and the appearance of Tdp have been recognized as potential risks during treatment with tyrosine kinase inhibitors.
26) The block of HERG by IM may contribute to its proarrythmic effects.
11) However, cases where IM induced QT prolongation and Tdp are relatively rare, and may be explained by additional calcium channel inhibition by the drug. 14, 16) It has been reported that calcium channel blocking can compensate for the proarrhythmic effects of the HERG blockade. 27, 28) Nonetheless, our findings provide a direct cellular mechanism for IM-induced QT interval prolongation and cardiac arrhythmia. Direct inhibition of the HERG channel may be of greater concern when IM is used in patients with congenital long QT syndrome, in patients with electrolyte abnormalities such as hypokalemia, or in patients receiving other QT intervalprolonging drugs.
In 2005, Kerkelä et al. provided the first evidence that IM-related cardiotoxicity manifested as severe congestive heart failure. Their results demonstrated that imatinib specifically induced cardiomyocyte apoptotic cell death by triggering endoplasmic reticulum stress and collapsed mitochondrial membrane potential via direct inhibition of c-Abl tyrosine kinase.
11) However, one of later studies presented evidence that IM-induced apoptosis may not be related to the inhibition of tyrosine kinase by the drug, 13) which suggested that some unknown mechanisms may be involved. Recently, one of our studies revealed that IM induced apoptosis via inhibition of HERG expression in CML, which may contribute to its clinical efficacy. 18) Furthermore, accumulated evidence demonstrated that the inhibition of HERG channels promotes apoptosis in HEK-293 cells and HL-1 cardiomyocytes. 29) Thus, HERG-related apoptosis may represent a process contributing to heart failure in patients treated with IM. Actually, the antihypertensive drug doxazosin, with HERG blocking properties, has already been shown to be associated with an increased incidence of heart failure. 29, 30) However, molecular mechanisms mediating HERG-related apoptosis are still unknown and require additional investigation.
The present study was designed to analyze the detail of the biophysical mechanism of HERG channel blockade by IM. An important finding of this study was that IM preferentially blocks the HERG channel while in an open state, with features similar to those of other open-channel blockers, including vesnarinone, 31) mesoridazine 32) and miconazole.
33)
The blocking effect developed after the channel opened and voltage range increased steeply as the channel opened, and the block developed in response to a depolarization pulse and/or envelope voltage protocol. This indicates that channel opening is required for the blockade of HERG channels by IM.
In the presence of IM, the activation V 1/2 of the HERG channels was shifted to a more negative potential, suggesting that IM affects the activation gating of the HERG channel. This shift can be explained by IM binding preferentially to the channel in an open state, thus limiting a HERG conductance increase at greater depolarized test potentials. Additionally, IM did not alter other channel kinetics (steady-state inactivation, onset of inactivation, and recovery from inactivation), indicating that IM had no effect on the inactivation gating of the HERG channel. These properties are similar to those of mesoridazine 32) and miconazole. 33) In summary, IM is a potent blocker of HERG channels, and it blocks the channels in a state-dependent manner.
To examine whether a key molecular determinant of the HERG blockade for previously investigated drugs are also important for HERG channels blocked by IM, we compared the potency of the channel block for WT and two mutant HERG channels (Y652A and F656A). Y652 and F656 sites are located on the S6 domain and face the central cavity of the channel. IM blocked HERG channels expressed in Xenopus oocytes had an IC 50 of 45 µmol/L, which was more than 2-fold lower compared to the HEK-293 cells. The lower potency of the drug blockade in oocytes compared with mammalian cells is a very common finding and may be related to the lipophilic yolk sac in oocytes. The potency of the channel blockade by IM was reduced in the two HERG mutant channels. The Y652A mutant increased the IC 50 by approximately 5.9-fold compared to the WT, while the F656A mutant increased the IC 50 of IM by 4.7-fold. As already stated, amino acids located on the S6 domain (Y652 and F656) have demonstrated to be important in high-affinity blockade for a number of compounds. 22, 23) In conclusion, the present study demonstrates that IM preferentially blocks open HERG channels in HEK-293 cells and Xenopus oocytes, and Tyr-652 and Phe-656 in the S6 domain are important molecular determinants for the blockade of the HERG channel by IM. our study represented the investigation of the direct interaction of IM with the cloned channels and inhibition of the HERG channel may contribute to IM-induced cardiotoxicity.
